Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers
A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. Scientists have demonstrated the potential efficacy of this approach a preclinical study.
Read Original Article: Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers »
